Keytruda (pembrolizumab) is an immunotherapy cancer treatment that stimulates the patient’s immune system to help fight certain types of cancers. Because cancer cells can use certain proteins, like the PD-1 protein, to shield themselves from detection, this enables cancer cells to grow and spread.
Opdivo (nivolumab) is an FDA- approved immunotherapy cancer drug treatment that is showing great promise for treating various types of cancer, including melanoma, lung cancer, kidney cancer and Hodgkin lymphoma. As a disease, cancer escapes the immune system by producing certain proteins that can hide it.
Jason Luke, MD, an assistant professor of Medicine at the University of Chicago Medicine, discusses some of the challenges that oncologists may face when administering immunotherapy agents to patients with melanoma